These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 38922160)

  • 21. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
    Sharma SK; Singh BR
    Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain.
    Pellett S; Tepp WH; Bradshaw M; Kalb SR; Dykes JK; Lin G; Nawrocki EM; Pier CL; Barr JR; Maslanka SE; Johnson EA
    mSphere; 2016; 1(1):. PubMed ID: 27303710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel therapeutic uses and formulations of botulinum neurotoxins: a patent review (2012 - 2014).
    Kane CD; Nuss JE; Bavari S
    Expert Opin Ther Pat; 2015 Jun; 25(6):675-90. PubMed ID: 25842964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic Approaches of Botulinum Toxin in Gynecology.
    Moga MA; Dimienescu OG; Bălan A; Scârneciu I; Barabaș B; Pleș L
    Toxins (Basel); 2018 Apr; 10(4):. PubMed ID: 29690530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative functional analysis of mice after local injection with botulinum neurotoxin A1, A2, A6, and B1 by catwalk analysis.
    Moritz MS; Tepp WH; Inzalaco HN; Johnson EA; Pellett S
    Toxicon; 2019 Sep; 167():20-28. PubMed ID: 31181297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum neurotoxin X lacks potency in mice and in human neurons.
    Gregg BM; Matsumura T; Wentz TG; Tepp WH; Bradshaw M; Stenmark P; Johnson EA; Fujinaga Y; Pellett S
    mBio; 2024 Mar; 15(3):e0310623. PubMed ID: 38347673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status and future directions of botulinum neurotoxins for targeting pain processing.
    Pellett S; Yaksh TL; Ramachandran R
    Toxins (Basel); 2015 Nov; 7(11):4519-63. PubMed ID: 26556371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NTNH protein: more than a bodyguard for botulinum neurotoxins.
    Gao L; Jin R
    FEBS J; 2024 Feb; 291(4):672-675. PubMed ID: 38009421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
    Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
    Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three enzymatically active neurotoxins of Clostridium botulinum strain Af84: BoNT/A2, /F4, and /F5.
    Kalb SR; Baudys J; Smith TJ; Smith LA; Barr JR
    Anal Chem; 2014 Apr; 86(7):3254-62. PubMed ID: 24605815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuronal selectivity of botulinum neurotoxins.
    Poulain B; Lemichez E; Popoff MR
    Toxicon; 2020 Apr; 178():20-32. PubMed ID: 32094099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unique biological activity of botulinum D/C mosaic neurotoxin in murine species.
    Nakamura K; Kohda T; Shibata Y; Tsukamoto K; Arimitsu H; Hayashi M; Mukamoto M; Sasakawa N; Kozaki S
    Infect Immun; 2012 Aug; 80(8):2886-93. PubMed ID: 22665374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical duration of action of different botulinum toxin types in humans.
    Eleopra R; Rinaldo S; Montecucco C; Rossetto O; Devigili G
    Toxicon; 2020 May; 179():84-91. PubMed ID: 32184153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Conservation of Tetanus and Botulinum Neurotoxins Cleavage Sites on Human SNARE Proteins Suggests That These Pathogens Exerted Little or No Evolutionary Pressure on Humans.
    Carle S; Pirazzini M; Rossetto O; Barth H; Montecucco C
    Toxins (Basel); 2017 Dec; 9(12):. PubMed ID: 29257047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative role of neurotoxin-associated proteins in the structural stability and endopeptidase activity of botulinum neurotoxin complex types A and E.
    Kukreja RV; Singh BR
    Biochemistry; 2007 Dec; 46(49):14316-24. PubMed ID: 18004882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurobiological mechanisms of botulinum neurotoxin-induced analgesia for neuropathic pain.
    Bagues A; Hu J; Alshanqiti I; Chung MK
    Pharmacol Ther; 2024 Jul; 259():108668. PubMed ID: 38782121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a unique ganglioside binding loop within botulinum neurotoxins C and D-SA .
    Karalewitz AP; Kroken AR; Fu Z; Baldwin MR; Kim JJ; Barbieri JT
    Biochemistry; 2010 Sep; 49(37):8117-26. PubMed ID: 20731382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Modified Recombinant Botulinum Neurotoxin Type F with Enhanced Potency.
    Burgin D; Périer C; Hackett G; Elliott M; Kwan D; Hornby F; Mir I; Maignel J; Liu SM; Beard M
    Toxins (Basel); 2021 Nov; 13(12):. PubMed ID: 34941672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitigating Immunogenicity by Coordinating Botulinum Toxin Treatments Between Aesthetics and Therapeutics.
    Gollomp SM; Khalifian S; Gokhale S
    Dermatol Surg; 2024 Sep; 50(9S):S35-S37. PubMed ID: 39196831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.